We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Assura Plc | LSE:AGR | London | Ordinary Share | GB00BVGBWW93 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.26 | -0.64% | 40.64 | 40.56 | 40.66 | 41.70 | 40.50 | 41.70 | 3,437,629 | 15:54:36 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Real Estate Agents & Mgrs | 150.4M | -119.2M | -0.0402 | -10.10 | 1.2B |
TIDMAGR
RNS Number : 5416D
Assura PLC
01 February 2018
1 February 2018
Assura plc
Trading Update
For the third quarter to 31 December 2017
GBP310m capital raised and promptly deployed
Assura plc ("Assura"), the UK's leading primary care property investor and developer, today publishes a trading update for the third quarter to 31 December 2017.
Value enhancing investment and development activity
We continued to make good progress in the third quarter, completing the acquisition of 22 medical centres and one development under a forward funding agreement at a combined cost of GBP84 million. These additions have a combined passing rent roll of GBP4.1 million and a weighted average unexpired lease length of 13.5 years.
Rental income increased
Assura now owns 498 medical centres with a total annualised rent roll of GBP87.4 million (30 September 2017: GBP83.1 million), with growth in the financial year to date driven primarily by acquisitions.
Secure and growing dividend
A key part of Assura's strategy is providing a secure, fully covered and growing dividend stream for investors. The quarterly dividend was increased by 9% for the January 2018 payment to 0.655 pence per share, equivalent to 2.62 pence per share on an annualised basis.
Financial position strengthened and capital deployed
In October 2017, Assura issued GBP150 million of unsecured eight and ten-year notes at a fixed rate of 3.04% and extended the Revolving Credit Facility by a further GBP50 million to GBP300 million.
In December 2017, Assura successfully raised a further GBP310 million from both existing and new investors, reflecting the strong support for our growth strategy. This capital has been swiftly deployed with GBP84 million of assets purchased by the end of December 2017 and in January 2018, we redeemed the Aviva secured debt of GBP211 million plus early repayment costs of GBP56 million.
Following this, gross debt stood at GBP430 million with undrawn facilities of GBP230 million.
Further details will be provided with the financial results for the year ended 31 March 2018, which are due to be released on 23 May 2018.
Market Background
GPs continue to highlight the challenges associated with a lack of space, poor layout and maintaining older buildings which are not fit for 21(st) century healthcare. As hospitals struggle to cope this winter, creating the infrastructure to allow more patients to be treated in the community is a key part of the solution. The autumn budget set out plans to invest GBP10 billion to make NHS buildings fit for the future, in line with the recommendations outlined in the Naylor Review, and we remain committed to playing our part. Assura joined with sector colleagues last summer to set out the potential for investment in primary care buildings through third party development, flagging that GBP3 billion could be invested over five years in the 'Primary Care Buildings Pledge'.
Jonathan Murphy, CEO, commented:
"Assura continued to make good progress in the third quarter, further diversifying its funding structure and investing in primary health care real estate. We remain confident in the outlook for the business for the full-year."
- Ends -
For more information, please contact:
Assura plc Tel: 01925 420660 Jonathan Murphy Jayne Cottam Orla Ball Edelman Tel: 0203 047 2546 John Kiely Mav Wynn Rob Yates
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2017, Assura's property portfolio was valued at GBP1,560 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTLLFIDLLILVIT
(END) Dow Jones Newswires
February 01, 2018 02:00 ET (07:00 GMT)
1 Year Assura Chart |
1 Month Assura Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions